I would like to extend my sympathies to Invocare share holders who have had their profit result impaired by a dissapointingly low death rate in the Australian community. A contributing factor has been the stabilisation of equity markets resulting in a moderation of heart attack rates amongst day traders. With the first flush of spring in the air, it doesn't appear as though business will pick up in the immediate future either. Rest assured that I will be doing all within my power to ensure an improvement in business conditions at the first available opportunity.
(The Grim) Reaper.
IVC Price at posting:
$6.40 Sentiment: None Disclosure: Not Held